Journal of Clinical Oncology, Vol 18, Issue 5
(March), 2000: 1135
© 2000 American Society for Clinical Oncology
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
By Amy R. Nelson,
Barbara Fingleton,
Mace L. Rothenberg,
Lynn M. Matrisian
From the Departments of Hematology/Oncology and Cell Biology, Vanderbilt University Medical Center, and the E. Bronson Ingram Cancer Center at Vanderbilt University, Nashville, TN.
Address reprint requests to Lynn M. Matrisian, PhD, Department of Cell Biology, Vanderbilt University Medical Center, T-2220, MCN, 1161 21st Ave South, Nashville, TN 37232; email lynn.matrisian@ mcmail.vanderbilt.edu.
ABSTRACT
ABSTRACT: Tumor progression is a complex, multistage process by which a normal cell undergoes genetic changes that result in phenotypic alterations and the acquisition of the ability to spread and colonize distant sites in the body. Although many factors regulate malignant tumor growth and spread, interactions between a tumor and its surrounding microenvironment result in the production of important protein products that are crucial to each step of tumor progression. The matrix metalloproteinases (MMPs) are a family of degradative enzymes with clear links to malignancy. These enzymes are associated with tumor cell invasion of the basement membrane and stroma, blood vessel penetration, and metastasis. They have more recently been implicated in primary and metastatic tumor growth and angiogenesis, and they may even have a role in tumor promotion. This review outlines our current understanding of the MMP family, including the association of particular MMPs with malignant phenotypes and the role of MMPs in specific steps of the metastatic cascade. As scientific understanding of the MMPs has advanced, therapeutic strategies that capitalize on blocking the enzymes have rapidly developed. The preclinical and clinical evolution of the synthetic MMP inhibitors (MMPIs) is also examined, with the discussion encompassing important methodologic issues associated with determining clinical efficacy of MMPIs and other novel therapeutic agents.
This article has been cited by other articles:
|
|
|
|
 
J. R. Newman, I. A. Bohannon, W. Zhang, J. B. Skipper, W. E. Grizzle, and E. L. Rosenthal
Modulation of Tumor Cell Growth In Vivo by Extracellular Matrix Metalloprotease Inducer
Arch Otolaryngol Head Neck Surg,
November 1, 2008;
134(11):
1218 - 1224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Brezski, J. L. Luongo, D. Petrone, M. H. Ryan, D. Zhong, S. H. Tam, A. P. Schmidt, M. Kruszynski, B. P. Whitaker, D. M. Knight, et al.
Human Anti-IgG1 Hinge Autoantibodies Reconstitute the Effector Functions of Proteolytically Inactivated IgGs
J. Immunol.,
September 1, 2008;
181(5):
3183 - 3192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Q. Yuan, L. Nicolson, B. Marchetti, E. A. Gault, M. S. Campo, and L. Nasir
Transcriptional Changes Induced by Bovine Papillomavirus Type 1 in Equine Fibroblasts
J. Virol.,
July 1, 2008;
82(13):
6481 - 6491.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Sasaki, T. Nakamura, R. B. Rebhun, H. Cheng, K. S. Hale, R. Z. Tsan, I. J. Fidler, and R. R. Langley
Modification of the Primary Tumor Microenvironment by Transforming Growth Factor {alpha}-Epidermal Growth Factor Receptor Signaling Promotes Metastasis in an Orthotopic Colon Cancer Model
Am. J. Pathol.,
July 1, 2008;
173(1):
205 - 216.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Kumar, S. Koul, L. Khandrika, R. B. Meacham, and H. K. Koul
Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype
Cancer Res.,
March 15, 2008;
68(6):
1777 - 1785.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. R. Radjabi, K. Sawada, S. Jagadeeswaran, A. Eichbichler, H. A. Kenny, A. Montag, K. Bruno, and E. Lengyel
Thrombin Induces Tumor Invasion through the Induction and Association of Matrix Metalloproteinase-9 and {beta}1-Integrin on the Cell Surface
J. Biol. Chem.,
February 1, 2008;
283(5):
2822 - 2834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Mulier, Y. Ni, J. Jamart, L. Michel, G. Marchal, and T. Ruers
Radiofrequency Ablation Versus Resection for Resectable Colorectal Liver Metastases: Time for a Randomized Trial?
Ann. Surg. Oncol.,
January 1, 2008;
15(1):
144 - 157.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Nangia-Makker, T. Raz, L. Tait, V. Hogan, R. Fridman, and A. Raz
Galectin-3 Cleavage: A Novel Surrogate Marker for Matrix Metalloproteinase Activity in Growing Breast Cancers
Cancer Res.,
December 15, 2007;
67(24):
11760 - 11768.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Thejass and G. Kuttan
Inhibition of Endothelial Cell Differentiation and Proinflammatory Cytokine Production During Angiogenesis by Allyl Isothiocyanate and Phenyl Isothiocyanate
Integr Cancer Ther,
December 1, 2007;
6(4):
389 - 399.
[Abstract]
[PDF]
|
|
|
|
|
|
|
B. Sun, S. Zhang, D. Zhang, X. Yin, S. Wang, Y. Gu, and Y. Wang
Doxycycline Influences Microcirculation Patterns in B16 Melanoma
Experimental Biology and Medicine,
November 1, 2007;
232(10):
1300 - 1307.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-F. Yang, P.-H. Wang, L.-Y. Lin, J.-L. Ko, G.-D. Chen, J.-S. Yang, H.-S. Lee, and Y.-S. Hsieh
A Significant Elevation of Plasma Level of Matrix Metalloproteinase 9 in Patients With High-Grade Intraepithelial Neoplasia and Early Squamous Cell Carcinoma of the Uterine Cervix
Reproductive Sciences,
October 1, 2007;
14(7):
710 - 718.
[Abstract]
[PDF]
|
|
|
|
|
|
|
P.-H. Wang, S.-F. Yang, G.-D. Chen, C.-P. Han, S.-C. Chen, L.-Y. Lin, and J.-L. Ko
Human Nonmetastatic Clone 23 Type 1 Gene Suppresses Migration of Cervical Cancer Cells and Enhances the Migration Inhibition of Fungal Immunomodulatory Protein From Ganoderma tsugae
Reproductive Sciences,
July 1, 2007;
14(5):
475 - 485.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Y.-S. Hsieh, S.-C. Chu, S.-F. Yang, P.-N. Chen, Y.-C. Liu, and K.-H. Lu
Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2
Carcinogenesis,
May 1, 2007;
28(5):
977 - 987.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Forster, T. Kahles, S. Kietz, and D. Drenckhahn
Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND
J. Physiol.,
May 1, 2007;
580(3):
937 - 949.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Harris, J. A. Green, P. T. Elkington, and J. S. Friedland
Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion
J. Leukoc. Biol.,
February 1, 2007;
81(2):
548 - 556.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. I. Gorodeski
Estrogen Decrease in Tight Junctional Resistance Involves Matrix-Metalloproteinase-7-Mediated Remodeling of Occludin
Endocrinology,
January 1, 2007;
148(1):
218 - 231.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Miyata, T. Iwata, K. Ohba, S. Kanda, M. Nishikido, and H. Kanetake
Expression of Matrix Metalloproteinase-7 on Cancer Cells and Tissue Endothelial Cells in Renal Cell Carcinoma: Prognostic Implications and Clinical Significance for Invasion and Metastasis
Clin. Cancer Res.,
December 1, 2006;
12(23):
6998 - 7003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Narazaki and G. Tosato
Conflicting results from clinical observations and murine models: what is the role of plasminogen activators in tumor growth?
J Natl Cancer Inst,
June 7, 2006;
98(11):
726 - 727.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.-S. Wang, P.-M. Chen, H.-S. Wang, W.-Y. Liang, and Y. Su
Matrix metalloproteinase-7 increases resistance to Fas-mediated apoptosis and is a poor prognostic factor of patients with colorectal carcinoma
Carcinogenesis,
May 1, 2006;
27(5):
1113 - 1120.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Blavier, A. Lazaryev, F. Dorey, G. M. Shackleford, and Y. A. DeClerck
Matrix metalloproteinases play an active role in wnt1-induced mammary tumorigenesis.
Cancer Res.,
March 1, 2006;
66(5):
2691 - 2699.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Mannello, G. A.M. Tonti, G. P. Bagnara, and S. Papa
Role and Function of Matrix Metalloproteinases in the Differentiation and Biological Characterization of Mesenchymal Stem Cells
Stem Cells,
March 1, 2006;
24(3):
475 - 481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Ii, H. Yamamoto, Y. Adachi, Y. Maruyama, and Y. Shinomura
Role of Matrix Metalloproteinase-7 (Matrilysin) in Human Cancer Invasion, Apoptosis, Growth, and Angiogenesis
Experimental Biology and Medicine,
January 1, 2006;
231(1):
20 - 27.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. H. Sun, Y. L. Sun, R. N. Fang, Y. Shao, H. C. Xu, Q. P. Xue, G. X. Ding, and Y. L. Cheng
Expression of Cyclooxygenase-2 and Matrix Metalloproteinase-9 in Gastric Carcinoma and its Correlation with Angiogenesis
Jpn. J. Clin. Oncol.,
December 1, 2005;
35(12):
707 - 713.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. W. Miller, S. Vosseler, N. Mirancea, D. J. Hicklin, P. Bohlen, H. E. Volcker, F. G. Holz, and N. E. Fusenig
Rapid Vessel Regression, Protease Inhibition, and Stromal Normalization upon Short-Term Vascular Endothelial Growth Factor Receptor 2 Inhibition in Skin Carcinoma Heterotransplants
Am. J. Pathol.,
November 1, 2005;
167(5):
1389 - 1403.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. P. Giacomini, S. Y. Leung, X. Chen, S. T. Yuen, Y. H. Kim, E. Bair, and J. R. Pollack
A Gene Expression Signature of Genetic Instability in Colon Cancer
Cancer Res.,
October 15, 2005;
65(20):
9200 - 9205.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fassnacht, J. Lee, C. Milazzo, D. Boczkowski, Z. Su, S. Nair, and E. Gilboa
Induction of CD4+ and CD8+ T-Cell Responses to the Human Stromal Antigen, Fibroblast Activation Protein: Implication for Cancer Immunotherapy
Clin. Cancer Res.,
August 1, 2005;
11(15):
5566 - 5571.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Fu, A. Ishizuya-Oka, D. R. Buchholz, T. Amano, H. Matsuda, and Y.-B. Shi
A Causative Role of Stromelysin-3 in Extracellular Matrix Remodeling and Epithelial Apoptosis during Intestinal Metamorphosis in Xenopus laevis
J. Biol. Chem.,
July 29, 2005;
280(30):
27856 - 27865.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Sosne, P. L. Christopherson, R. P. Barrett, and R. Fridman
Thymosin-{beta}4 Modulates Corneal Matrix Metalloproteinase Levels and Polymorphonuclear Cell Infiltration after Alkali Injury
Invest. Ophthalmol. Vis. Sci.,
July 1, 2005;
46(7):
2388 - 2395.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Mazzocca, R. Coppari, R. De Franco, J.-Y. Cho, T. A. Libermann, M. Pinzani, and A. Toker
A Secreted Form of ADAM9 Promotes Carcinoma Invasion through Tumor-Stromal Interactions
Cancer Res.,
June 1, 2005;
65(11):
4728 - 4738.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Nosho, M. Yoshida, H. Yamamoto, H. Taniguchi, Y. Adachi, M. Mikami, Y. Hinoda, and K. Imai
Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis
Carcinogenesis,
May 1, 2005;
26(5):
892 - 899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ruokolainen, P. Paakko, and T. Turpeenniemi-Hujanen
Tissue Inhibitor of Matrix Metalloproteinase-1 Is Prognostic in Head and Neck Squamous Cell Carcinoma: Comparison of the Circulating and Tissue Immunoreactive Protein
Clin. Cancer Res.,
May 1, 2005;
11(9):
3257 - 3264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y. Tang, M. T. Nakada, P. Kesavan, F. McCabe, H. Millar, P. Rafferty, P. Bugelski, and L. Yan
Extracellular Matrix Metalloproteinase Inducer Stimulates Tumor Angiogenesis by Elevating Vascular Endothelial Cell Growth Factor and Matrix Metalloproteinases
Cancer Res.,
April 15, 2005;
65(8):
3193 - 3199.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Jodele, C. F. Chantrain, L. Blavier, C. Lutzko, G. M. Crooks, H. Shimada, L. M. Coussens, and Y. A. DeClerck
The Contribution of Bone Marrow-Derived Cells to the Tumor Vasculature in Neuroblastoma Is Matrix Metalloproteinase-9 Dependent
Cancer Res.,
April 15, 2005;
65(8):
3200 - 3208.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Ogawa, T. Utsunomiya, K. Mimori, F. Tanaka, H. Inoue, H. Nagahara, S. Murayama, and M. Mori
Clinical Significance of Human Kallikrein Gene 6 Messenger RNA Expression in Colorectal Cancer
Clin. Cancer Res.,
April 15, 2005;
11(8):
2889 - 2893.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X.-F. Wang, J. Z. Cui, S. S. Prasad, and J. A. Matsubara
Altered Gene Expression of Angiogenic Factors Induced by Calcium-Mediated Dissociation of Retinal Pigment Epithelial Cells
Invest. Ophthalmol. Vis. Sci.,
April 1, 2005;
46(4):
1508 - 1515.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-H. Xia, J. Wang, and J. X. Kang
Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes
Carcinogenesis,
April 1, 2005;
26(4):
779 - 784.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Meuwissen and A. Berns
Mouse models for human lung cancer
Genes & Dev.,
March 15, 2005;
19(6):
643 - 664.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Vosseler, N. Mirancea, P. Bohlen, M. M. Mueller, and N. E. Fusenig
Angiogenesis Inhibition by Vascular Endothelial Growth Factor Receptor-2 Blockade Reduces Stromal Matrix Metalloproteinase Expression, Normalizes Stromal Tissue, and Reverts Epithelial Tumor Phenotype in Surface Heterotransplants
Cancer Res.,
February 15, 2005;
65(4):
1294 - 1305.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Bissett, K. J. O'Byrne, J. von Pawel, U. Gatzemeier, A. Price, M. Nicolson, R. Mercier, E. Mazabel, C. Penning, M. H. Zhang, et al.
Phase III Study of Matrix Metalloproteinase Inhibitor Prinomastat in Non-Small-Cell Lung Cancer
J. Clin. Oncol.,
February 1, 2005;
23(4):
842 - 849.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. Xu, Y. Wang, Z. Chen, M. D. Sternlicht, M. Hidalgo, and B. Steffensen
Matrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen
Cancer Res.,
January 1, 2005;
65(1):
130 - 136.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Ravanko, K. Jarvinen, J. Helin, N. Kalkkinen, and E. Holtta
Cysteine Cathepsins Are Central Contributors of Invasion by Cultured Adenosylmethionine Decarboxylase-Transformed Rodent Fibroblasts
Cancer Res.,
December 15, 2004;
64(24):
8831 - 8838.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. A. Sparano, P. Bernardo, P. Stephenson, W. J. Gradishar, J. N. Ingle, S. Zucker, and N. E. Davidson
Randomized Phase III Trial of Marimastat Versus Placebo in Patients With Metastatic Breast Cancer Who Have Responding or Stable Disease After First-Line Chemotherapy: Eastern Cooperative Oncology Group Trial E2196
J. Clin. Oncol.,
December 1, 2004;
22(23):
4683 - 4690.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-W. CHUNG, S.-K. MOON, Y.-C. CHANG, J.-H. KO, Y.-C. LEE, G. CHO, S.-H. KIM, J.-G. KIM, and C.-H. KIM
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism
FASEB J,
November 1, 2004;
18(14):
1670 - 1681.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Jayasankar, Y. J. Woo, L. T. Bish, T. J. Pirolli, M. F. Berry, J. Burdick, R. C. Bhalla, R. V. Sharma, T. J. Gardner, and H. L. Sweeney
Inhibition of Matrix Metalloproteinase Activity by TIMP-1 Gene Transfer Effectively Treats Ischemic Cardiomyopathy
Circulation,
September 14, 2004;
110(11_suppl_1):
II-180 - II-186.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. S. Aljada, N. Ramnath, K. Donohue, S. Harvey, J. J. Brooks, S. M. Wiseman, T. Khoury, G. Loewen, H. K. Slocum, T. M. Anderson, et al.
Upregulation of the Tissue Inhibitor of Metalloproteinase-1 Protein Is Associated With Progression of Human Non-Small-Cell Lung Cancer
J. Clin. Oncol.,
August 15, 2004;
22(16):
3218 - 3229.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Aalinkeel, M. P. N. Nair, G. Sufrin, S. D. Mahajan, K. C. Chadha, R. P. Chawda, and S. A. Schwartz
Gene Expression of Angiogenic Factors Correlates with Metastatic Potential of Prostate Cancer Cells
Cancer Res.,
August 1, 2004;
64(15):
5311 - 5321.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Saghatelian, N. Jessani, A. Joseph, M. Humphrey, and B. F. Cravatt
Activity-based probes for the proteomic profiling of metalloproteases
PNAS,
July 6, 2004;
101(27):
10000 - 10005.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Maquoi, N. E. Sounni, L. Devy, F. Olivier, F. Frankenne, H.-W. Krell, F. Grams, J.-M. Foidart, and A. Noel
Anti-Invasive, Antitumoral, and Antiangiogenic Efficacy of a Pyrimidine-2,4,6-trione Derivative, an Orally Active and Selective Matrix Metalloproteinases Inhibitor
Clin. Cancer Res.,
June 15, 2004;
10(12):
4038 - 4047.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. K. Vayalil, A. Mittal, and S. K. Katiyar
Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NF{kappa}B
Carcinogenesis,
June 1, 2004;
25(6):
987 - 995.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Alvarez-Sabin, P. Delgado, S. Abilleira, C. A. Molina, J. Arenillas, M. Ribo, E. Santamarina, M. Quintana, J. Monasterio, and J. Montaner
Temporal Profile of Matrix Metalloproteinases and Their Inhibitors After Spontaneous Intracerebral Hemorrhage: Relationship to Clinical and Radiological Outcome
Stroke,
June 1, 2004;
35(6):
1316 - 1322.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T Kirkegaard, A Hansen, E Bruun, and J Brynskov
Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease
Gut,
May 1, 2004;
53(5):
701 - 709.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Ruokolainen, P. Paakko, and T. Turpeenniemi-Hujanen
Expression of Matrix Metalloproteinase-9 in Head and Neck Squamous Cell Carcinoma: A Potential Marker for Prognosis
Clin. Cancer Res.,
May 1, 2004;
10(9):
3110 - 3116.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. E. Jones, M. J. Humphreys, F. Campbell, J. P. Neoptolemos, and M. T. Boyd
Comprehensive Analysis of Matrix Metalloproteinase and Tissue Inhibitor Expression in Pancreatic Cancer: Increased Expression of Matrix Metalloproteinase-7 Predicts Poor Survival
Clin. Cancer Res.,
April 15, 2004;
10(8):
2832 - 2845.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ferrario, C. F. Chantrain, K. von Tiehl, S. Buckley, N. Rucker, D. R. Shalinsky, H. Shimada, Y. A. DeClerck, and C. J. Gomer
The Matrix Metalloproteinase Inhibitor Prinomastat Enhances Photodynamic Therapy Responsiveness in a Mouse Tumor Model
Cancer Res.,
April 1, 2004;
64(7):
2328 - 2332.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. A. Rizvi, J. S. Humphrey, E. A. Ness, M. D. Johnson, E. Gupta, K. Williams, D. J. Daly, D. Sonnichsen, D. Conway, J. Marshall, et al.
A Phase I Study of Oral BMS-275291, a Novel Nonhydroxamate Sheddase-Sparing Matrix Metalloproteinase Inhibitor, in Patients with Advanced or Metastatic Cancer
Clin. Cancer Res.,
March 15, 2004;
10(6):
1963 - 1970.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. F. Chantrain, H. Shimada, S. Jodele, S. Groshen, W. Ye, D. R. Shalinsky, Z. Werb, L. M. Coussens, and Y. A. DeClerck
Stromal Matrix Metalloproteinase-9 Regulates the Vascular Architecture in Neuroblastoma by Promoting Pericyte Recruitment
Cancer Res.,
March 1, 2004;
64(5):
1675 - 1686.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
